Synthetic DNA and mRNA* on demand
Our solutions address the needs of the synthetic biology industry and academia, across discovery and pre-clinical development, by providing an unmatched capability to synthesize high-quality DNA, regardless of vector size and complexity, and biologically active mRNA* within 24 hours. Our BioXp™ system is a hands-free, automated platform, that enables reduced turnaround time from weeks to days, increased throughput and scale, enhanced quality, complete workflow control and both synthetic DNA and mRNA* formats.
Our goal is to address the continuum of research needs across the central dogma of biology by enabling cell-free production of high-quality synthetic DNA, mRNA* and proteins* for the discovery, development and manufacturing of core enabled products across a wide range of markets. We provide workflow solutions for research, clinical and healthcare, and technology.
Our solutions combine the BioXp™ system and application-specific BioXp™ kits (by endpoint product) to provide a workflow solution tailored to meet the needs of the customer.
Learn about our synthetic DNA and mRNA* for application workflows
Genome synthesis + engineering
Infectious disease vaccine discovery + development
Metabolic pathway engineering
Vaccines for precision medicine
Antibody + protein engineering of biologic drugs
*Not yet available for sale. No guarantee of release is implied.